Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance
Go back to Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 77.62 +4.75 (6.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.87 | 52 Week High | $39.41 | |||
| Open | $72.85 | 52 Week Low | $25.98 | |||
| Day High | $77.70 | P/E | 109.32 | |||
| Day Low | $72.04 | EPS | $0.71 | |||
| Volume | 746,058 | |||||
